当前位置：首页 > 文献互助 > 互助详情

Thromboembolic Complications in Continuous Versus Interrupted Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation: A Multicenter Study复制

用户mKQO0T3T2ANY 4天前 33 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2025-07-14 17:08:13 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1097/cce.0000000000001155复制

文献链接: https://journals.lww.com/10.1097/CCE.0000000000001155复制

其他信息:

出版社: Ovid Technologies (Wolters Kluwer Health)
作者: William Miller; Jacob Braaten; Anna Rauzi; Jillian Wothe; Kristiana Sather; Angela Phillips; Danika Evans; Ramiro Saavedra-Romero; Matthew Prekker; Melissa E. Brunsvold

上一篇：High And Intermediate-High Risk Pulmonary Embolism Management: A 5-Year Intensive Care Unit Casuistic Review

下一篇：Tranexamic Acid Use for Hemorrhagic Events Prevention in Percutaneous Nephrolithotomy: Systematic Review and Meta-Analysis

互助时间线

2025-07-07 17:19:49 [完结求助]

楼主确认了经典阅读应助的文件是正确的, 求助状态变成 已完结

2025-07-07 17:08:13 [上传文件]

经典阅读上传了文件(pdf 898.60 KB), 求助状态变成 待确认

2025-07-07 16:01:09 [发起求助]

最新发布的求助

Discovery of a Novel EGFR PROTAC Degrader against C797S Resistance Mutation with Potent Antitumor Efficacy in NSCLC Treatment 11分钟前
Echolocation over long distances 1小时前
Nitroxide radical contrast agents for safe magnetic resonance imaging: progress, challenges, and perspectives 3小时前
Smart cities for emergency management 3小时前
Oral ENPP1 inhibitor designed using generative Al as next generation STiNG modulator for solid tumors 13小时前
癌患者の痛みに対する塩酸モルヒネ坐剤AN-631の有用性の検討 －硫酸モルヒネ徐放錠との比較― 16小时前
癌患者の疼痛治療におけるAN-631H(塩酸モルヒネ坐剤30mg)の臨床評価 16小时前
Regulatory T cells in the tumour microenvironment 17小时前
POS0734 DAPIROLIZUMAB PEGOL 显示系统性红斑狼疮疾病活动有显着改善：疗效 ... 17小时前
Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial 18小时前
Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer 18小时前
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma 18小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com